title: Vertical transmission of hypopituitarism: critical importance of appropriate interpretation of thyroid function tests and levothyroxine therapy during pregnancy.
abstract: BACKGROUND
  Typically, newborns with congenital hypothyroidism are asymptomatic at birth, having been exposed to euthyroid mothers. However, hypopituitarism may be associated with central hypothyroidism, preserved fertility, and autosomal dominant inheritance, requiring increased attention to thyroid management during pregnancy.
  
  
  METHODS
  A woman with a history of growth hormone deficiency and central hypothyroidism gave birth to a term male neonate appropriate for gestational age. Due to low thyrotropin (TSH) in the second trimester, the levothyroxine dose was decreased by the obstetrician, and free T4 was low throughout the latter half of pregnancy. The neonatal laboratory evaluation showed central hypothyroidism with a low T4 of 2.1 μg/dL (4.5-11.5) and an inappropriately normal TSH of 0.98 uIU/mL (0.5-4.5); undetectable growth hormone, IGF-I, and IGFBP3; a normal cortisol level; and a normal gonadotropin surge. After initiation of levothyroxine in the first week, both tone and feeding tolerance improved. However, the patient was found to have hearing loss, gross motor delay, and speech delay.
  
  
  CONCLUSIONS
  In this report, we review a case of vertical transmission of a dominant negative POU1F1 mutation in which fetal abnormalities due to the hypothyroxinemic state during gestation may have been exacerbated by a decrease in the mother's levothyroxine dose based on a low TSH in early gestation. Both mother and fetus were unable to synthesize sufficient thyroid hormone, which may be responsible for the patient's clinical presentation.
  
  
  CONCLUSIONS
  This case underscores several important points in the management of women with hypopituitarism. First, it is important that patients and clinicians are both aware of the differences in etiology, as well as appropriate screening and treatment, of primary versus central hypothyroidism. Second, it is necessary to monitor the thyroid hormone status closely during pregnancy to prevent fetal sequelae of maternal hypothyroidism. Third, genetic screening of patients with combined pituitary hormone deficiency is necessary, so that prenatal genetic counseling may be an option for expecting parents.
authors: Department of Pediatrics, University of Maryland, Baltimore, Maryland 21201, USA. epine@peds.umaryland.edu
authors: Elyse
authors: E
authors: Pine-Twaddell
authors: Christopher J
authors: CJ
authors: Romero
authors: Sally
authors: S
authors: Radovick
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics; D000328:Adult; D005260:Female; D019382:Human Growth Hormone / Q000172:deficiency; D006801:Humans; D007018:Hypopituitarism / Q000235:genetics*; D007037:Hypothyroidism / Q000188:drug therapy / Q000235:genetics* / Q000517:prevention & control; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000503:physiopathology*; D011262:Pregnancy Trimester, Second; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use*; D050817:Transcription Factor Pit-1 / Q000235:genetics*
chemical_list: C494187:POU1F1 protein, human; D050817:Transcription Factor Pit-1; D019382:Human Growth Hormone; D013972:Thyrotropin; D013974:Thyroxine
references: J Clin Endocrinol Metab. 2008 Mar;93(3):1062-71
references: 18073311
references: Science. 1992 Aug 21;257(5073):1115-8
references: 1509262
references: N Engl J Med. 2004 Jul 15;351(3):241-9
references: 15254282
references: J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65
references: 22869843
references: J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S225-33
references: 20195902
references: Ir J Med Sci. 2010 Dec;179(4):621-2
references: 20878259
references: Clin Endocrinol (Oxf). 1999 Feb;50(2):149-55
references: 10396355
references: J Pediatr. 2010 Jun;156(6):1026-1029
references: 20304420
references: Thyroid. 2012 Dec;22(12):1197-9
references: 23210565
references: Am J Obstet Gynecol. 2008 Jul;199(1):62.e1-6
references: 18585522
references: J Clin Endocrinol Metab. 1995 Nov;80(11):3127-30
references: 7593413
references: Thyroid. 1999 Jul;9(7):735-40
references: 10447022
references: J Pediatr. 1986 Dec;109(6):959-64
references: 3783339
references: Biochem Biophys Res Commun. 1992 Dec 15;189(2):851-5
references: 1472057
references: Thyroid. 2011 Oct;21(10):1081-125
references: 21787128
references: Thyroid. 2004 Dec;14(12):1084-90
references: 15650363
references: Eur J Pediatr. 1997 Nov;156(11):829-34
references: 9392392
references: Int J Gynaecol Obstet. 2002 Nov;79(2):171-80
references: 12481755
references: Pituitary. 2006;9(4):335-42
references: 17077946
references: Clin Endocrinol (Oxf). 2005 Feb;62(2):163-8
references: 15670191
references: J Clin Endocrinol Metab. 2008 Jul;93(7):2790-9
references: 18445675
references: Mamm Genome. 2007 Aug;18(8):596-608
references: 17899304
references: J Clin Endocrinol Metab. 2007 Aug;92(8 Suppl):S1-47
references: 17948378
references: N Engl J Med. 1990 Jul 12;323(2):91-6
references: 2359428
references: J Clin Endocrinol Metab. 2001 May;86(5):2009-14
references: 11344199
references: Obstet Gynecol Clin North Am. 2010 Jun;37(2):173-93
references: 20685547
references: J Neurosci. 2009 Jan 28;29(4):1212-23
references: 19176829
references: Clin Endocrinol (Oxf). 2003 Sep;59(3):282-8
references: 12919150
references: Clin Endocrinol (Oxf). 2011 Feb;74(2):262-9
references: 21044115
references: Obstet Gynecol. 2007 May;109(5):1129-35
references: 17470594
references: N Engl J Med. 1999 Aug 19;341(8):549-55
references: 10451459
references: Thyroid. 2012 Dec;22(12):1200-35
references: 22954017